Two breast cancer cell lines, MDA-MB-231 (lacking HER2 overexpression) and SK-BR-3 (HER2-overexpressing) were thus treated with concentrated VLPs, diluted at 1/10. The gene discussed is ERBB2; the disease is breast cancer.